TY  - GEN
AU  - Anderson,Mary Ann
AU  - Tam,Constantine
AU  - Lew,Thomas E
AU  - Juneja,Surender
AU  - Juneja,Manu
AU  - Westerman,David
AU  - Wall,Meaghan
AU  - Lade,Stephen
AU  - Gorelik,Alexandra
AU  - Huang,David C S
AU  - Seymour,John F
AU  - Roberts,Andrew W
TI  - Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax
SN  - 1528-0020
PY  - 2017///0828
KW  - Adult
KW  - Agammaglobulinaemia Tyrosine Kinase
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Bridged Bicyclo Compounds, Heterocyclic
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Karyotype
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Retrospective Studies
KW  - Sulfonamides
KW  - Treatment Outcome
KW  - Vidarabine
KW  - analogs & derivatives
KW  - Young Adult
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1182/blood-2017-01-763003
ER  -